Schedule 13G ownership disclosure

IO BIOTECH INC

Common stock, par value $0.001 per share · CUSIP: 449778109

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vivo Capital IX, LLC

    Shares: 0.00 · Class: 0%

  • Vivo Capital Fund IX, L.P.

    Shares: 0.00 · Class: 0%

  • Vivo Opportunity, LLC

    Shares: 3,157,894.00 · Class: 4.6%

  • Vivo Opportunity Fund Holdings, L.P.

    Shares: 3,157,894.00 · Class: 4.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-111138
Form type
SCHEDULE 13G/A
Filer
IO Biotech, Inc.
CIK
CIK 1865494
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub